Institut National de la Santé et de la Recherche Médicale (INSERM)

USPTO Trademark & Patent Filings

Trademark applications and grants for Institut National De La Santé Et De La Recherche Médicale (inserm). Institut National De La Santé Et De La Recherche Médicale (inserm) has 7 trademark applications. The latest application filed is for "SCENITH"

Company Profile

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
inserm medicale recherche la de et sante la de national institut
Institut National de la Sante et de la Recherche Medicale (INSERM) - Paris FR
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE - (INSERM) - PARIS FR
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) - Paris FR
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) - INSERM

State Incorporated	FRANCE
Entity Type	state agency
Address	101 rue de Tolbiac Paris FRANCE F-75013

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks Patents

Patent Applications

Patent Application	Date
In Vitro Method for the Prognosis of Progression of a Cancer and of the Outcome in a Patient and Means for Performing Said Method 20220308063 - 17/687169 Galon; Jerome ; et al.	2022-09-29
ENDONUCLEASE-BARCODING 20220307012 - 17/824063 Grumolato; Luca	2022-09-29
METHOD FOR GENERATING A BIOMARKER, SYSTEM 20220301158 - 17/631258 DOURNES; Gael ; et al.	2022-09-22
TRACKED VEHICLE FOR THE TRANSPORTATION OF REDUCED MOBILITY PERSONS 20220296441 - 17/639352 CARTA; Jean-Paul ; et al.	2022-09-22
QUALITY CONTROL DEVICES AND METHODS FOR MAGNETIC RESONANCE IMAGING SYSTEMS 20220291315 - 17/633328 DESTRIEUX; Christophe ; et al.	2022-09-15
Bordetella strains expressing serotype 3 fimbriae 11,446,372 - 16/848,793 Debrie , et al. September 20, 2	2022-09-20
Bordetella strains expressing serotype 3 fimbriae 11,446,372 - 16/848,793 Debrie , et al. September 20, 2	2022-09-20
Compositions useful in the diagnostic of latently infected Mycobacterium tuberculosis 11,448,656 - 16/037,150 Iovanna , et al. September 20, 2	2022-09-20
Method for rejuvenating cells 11,414,649 - 16/704,064 Prieur , et al. August 16, 2	2022-08-16
Selective organic cation transporters inhibitors for the treatment of depressive disorders 11,414,398 - 16/630,082 Gautron , et al. August 16, 2	2022-08-16

Patent Grants & Applications

Trademark Applications

Mark Image Registration \| Serial	Trademark Application Date
"SCENITH" 97770274	SCENITH 2023-01-27
"LINCTOBC" 79332438	LINCTOBC 2021-11-17
"SUN TO BRAIN HEALTH" 79329445	SUN TO BRAIN HEALTH 2021-11-10
"ORPHANET" 90559344	ORPHANET 2021-03-04
"TCA" 79182184	TCA 2015-11-09
"PARK-MEDATLIS" 5029175 79174636	PARK-MEDATLIS 2015-03-12
"ORPHANET" 3728934 77237451	ORPHANET 2007-07-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.